Home » Markets

Lathrop Investment Management Corp Sells 173 Shares of Lam Research Co. (NASDAQ:LRCX)

Posted by Gary Stephens on Nov 22nd, 2024

Lathrop Investment Management Corp reduced its stake in shares of Lam Research Co. (NASDAQ:LRCX – Free Report) by 2.8% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange... More of this article »

Lathrop Investment Management Corp Has $16.65 Million Stock Position in Jacobs Solutions Inc. (NYSE:J)

Posted by Shelly Janes on Nov 22nd, 2024

Lathrop Investment Management Corp decreased its holdings in shares of Jacobs Solutions Inc. (NYSE:J – Free Report) by 1.2% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor... More of this article »

Nwam LLC Purchases New Holdings in Vanguard Short-Term Corporate Bond ETF (NASDAQ:VCSH)

Posted by Emily Schoerning on Nov 22nd, 2024

Nwam LLC purchased a new position in shares of Vanguard Short-Term Corporate Bond ETF (NASDAQ:VCSH – Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund purchased... More of this article »

QuantumScape (NYSE:QS) Upgraded at Hsbc Global Res

Posted by Karen Miller on Nov 22nd, 2024

Hsbc Global Res upgraded shares of QuantumScape (NYSE:QS – Free Report) to a hold rating in a research note released on Tuesday,Zacks.com reports. A number of other equities research analysts have also weighed in on the company.... More of this article »

Replimune Group (NASDAQ: REPL) Submits Biologics License Application for RP1 in Combination with Nivolumab to FDA

Posted by Christopher Mengel on Nov 22nd, 2024

On November 21, 2024, Replimune Group, Inc. (NASDAQ: REPL) made significant strides in the advancement of its lead product candidate, RP1. The company announced the submission of a biologics license application (BLA) to the U.S. Food... More of this article »